BridgeBio has substantially improved its course of an novel therapy for amyloid heart disease, leveraging the compound. Initial clinical data reveals potential benefits for patients affected with the debilitating condition. This focus highlights BridgeBio's dedication to treating significant patient requirements in a heart field. Attrub… Read More